학술논문

Nab-paclitaxel in combination with carboplatin as first line therapy for patients with stage IIIB/IV NSCLC in the real-world setting: Interim results of the NEPTUN study
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; 2018, 41 p296-p296, 1p. Supplement: 4
Subject
Language
English
ISSN
22965262